US Pharma and Biotech Summit
The Financial Times US Pharma & Biotech Summit returns in May 2023 for two days of insightful analysis and discussion on key topics including drug discovery, clinical trials, market access, portfolio management and stakeholder engagement.
As pharmaceutical and biotechnology companies continue to innovate in a disrupted world, industry leaders will gather in New York to address the challenges and opportunities of today and tomorrow, from building partnerships and developing new treatments to investing in technology and preparing for the next global health emergency.
Join us in-person and online as we explore new frontiers for business and for healthcare. Learn from renowned experts, engage with prominent CEOs and network with peers in a friendly but focused environment.
Why Attend?
Understand
How pharma’s role in American healthcare is evolving through innovation in R&D, drug delivery and patient access
Connect
With some of the biggest names in the industry to learn about the latest trends, exchange ideas and build relationships
Discover
New approaches to drug development with the potential to transform pipelines and bring products to market faster
The 2022 Summit featured world-class speakers including:
Key themes
Investment
Where are investors in American life sciences putting their money?
Partnerships
How can public and private stakeholders collaborate beyond the pandemic?
Innovation
What are some of the latest breakthroughs in advanced therapies?
Transformation
How are pharma and biotech operating models evolving?
Regulation
How is the approval process for drugs evolving in the US?
Patients
Why is patient centricity important?
Become a sponsor
Contact holly.watson-steward@ft.com to discuss partnership opportunities that work best for you and your business objectives. Engage directly with influential leaders and organizations across the industry.
Not a subscriber of the FT?
When you purchase a ticket to one of our events you will receive a trial subscription for £1 giving you full digital access to essential news and opinion.
Speaking Opportunities
Ciaran Larkin
ciaran.larkin@ft.com
Sponsorship Opportunities
Holly Watson-Steward
holly.watson-steward@ft.com
Delegate Services
Sean Hammond
sean.hammond@ft.com
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice